STOCK TITAN

Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Harrow (Nasdaq: HROW) will announce its third-quarter financial results for the period ending September 30, 2022, on November 14, 2022, after market close. A conference call will follow at 4:45 p.m. Eastern Time to discuss the results and company updates. Investors can access related materials through Harrow's website. The company is dedicated to developing innovative, affordable ophthalmic therapies.

Positive
  • Focus on developing innovative ophthalmic therapies may drive future growth.
Negative
  • None.

NASHVILLE--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update.

Conference Call Details:

 

Date:

Monday, November 14, 2022

Time:

4:45 p.m. Eastern time

Participant Dial-in:

1-833-953-2434 (U.S.)
1-412-317-5763 (International)

Replay Dial-in (Passcode 7735845):

(telephonic replay through November 21, 2022)

1-877-344-7529 (U.S.)
1-412-317-0088 (International)

Webcast: (online replay through February 14, 2023)

harrowinc.com

About Harrow

Harrow (Nasdaq: HROW) is an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies that are accessible and affordable. For more information about Harrow, including investor-related materials, please visit the corporate website, harrowinc.com, or Harrow’s LinkedIn page.

Jamie Webb, Director of Communications and Investor Relations

jwebb@harrowinc.com

615-733-4737

Source: Harrow

FAQ

When will Harrow release its Q3 financial results?

Harrow will release its Q3 financial results on November 14, 2022, after market close.

What time is Harrow's conference call on November 14, 2022?

The conference call will take place at 4:45 p.m. Eastern Time.

Where can I find Harrow's third quarter Letter to Stockholders?

The Letter to Stockholders will be posted in the 'Investors' section of Harrow's website.

How can I join Harrow's conference call?

To join the conference call, dial 1-833-953-2434 (U.S.) or 1-412-317-5763 (International).

Harrow, Inc.

NASDAQ:HROW

HROW Rankings

HROW Latest News

HROW Stock Data

1.27B
30.81M
13.49%
59.29%
8.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
NASHVILLE